臨床試験

Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease

NCT: NCT05295615 · RECRUITING

NCT識別子NCT05295615

ステータスRECRUITING

開始日2023-05-01

完了2027-09-30

SponsorHerrick Medical LLC (INDUSTRY)

First posted2022-03-25

Last updated2026-09-17

概要

An open label pilot study in mild to moderate AD patients to assess the effects of treatment with ECHS AD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end points are the The Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Mini-Mental State Exam. Participants will be followed-up for 9 months post-treatment.

公式ソース

ClinicalTrials.govで見る →

データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。